-
Bearish MACD for West Pharma - Tale of the Tape
Tuesday, January 25, 2011 - 11:59am | 115West Pharmaceutical Services Inc.'s (WST) MACD indicator has entered into bearish territory with a reading of -0.2556. The Zacks #4 Rank (“Sell”) stock decreased slightly to $39.37 in morning trade. The Zacks Consensus Estimate for the year ended December 2010 has decreased by a penny over the past...
-
Neogen's Tests for Salmonella In Feed Meet FDA Draft Guidance
Tuesday, January 25, 2011 - 10:17am | 133Neogen Corporation (Nasdaq: NEOG) today announced that its rapid tests for Salmonella meet the guidance for Salmonella in animal feed currently being considered by the FDA. The FDA's proposed guidance for Salmonella in animal feed seeks to lessen the number of human illnesses linked to contact with...
-
Anika Therapeutics Appoints Jeffery S. Thompson to its Board
Thursday, January 20, 2011 - 10:08am | 66Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that it has appointed Jeffery S. Thompson, Chairman and Chief Executive Officer of Advanced Bio-Technologies, Inc., to its Board of Directors. ABT is a Georgia-based biopharmaceutical company specializing in the treatment and management of...
-
Citigroup Downgrades Alcon To Hold
Thursday, January 20, 2011 - 7:50am | 27Citigroup has downgraded Alcon, Inc. (NYSE: ACL) from Buy to Hold and has lowered the price target from $181 to $168.
-
Cooper Rolls Out Avaira Toric Ahead Of Schedule
Wednesday, January 19, 2011 - 9:47am | 140Jefferies & Company has published a research report on Cooper Companies (NYSE: COO) as CooperVision introduces its Avaira Toric nationwide ahead of schedule. In the report, Jefferies writes "COO initially introduced the Avaira Toric lens in test markets outside of the U.S. during its FQ2:10 (...
-
Cooper Rolls Out Avaira Toric Ahead Of Schedule
Wednesday, January 19, 2011 - 9:47am | 140Jefferies & Company has published a research report on Cooper Companies (NYSE: COO) as CooperVision introduces its Avaira Toric nationwide ahead of schedule. In the report, Jefferies writes "COO initially introduced the Avaira Toric lens in test markets outside of the U.S. during its FQ2:10 (...
-
Cooper Launches Avaira Toric - Analyst Blog
Wednesday, January 19, 2011 - 9:31am | 583CooperVision, a part of The Cooper Companies Inc (COO), the leading manufacturer of soft contact lenses, recently rolled out the Avaira Toric silicone hydrogel lenses for astigmatic patients in the domestic market. This latest addition to the Avaira family offers special help for such patients...
-
Cooper Launches Avaira Toric - Analyst Blog
Wednesday, January 19, 2011 - 9:00am | 583CooperVision, a part of The Cooper Companies Inc (COO), the leading manufacturer of soft contact lenses, recently rolled out the Avaira Toric silicone hydrogel lenses for astigmatic patients in the domestic market. This latest addition to the Avaira family offers special help for such patients...
-
Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Profit Margin (TRIB, AXK, BLUD, VIVO)
Tuesday, January 18, 2011 - 4:22am | 128Below are the top small-cap diagnostic substance stocks on the NYSE, the NASDAQ and the AMEX in terms of profit margin. The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB) is 59.32%. TRIB's PEG ratio is 1.60. The trailing-twelve-month profit margin at Accelr8 Technology...
-
Best Biotech Stocks To Own Now (CRIS, CGEN, SPPI, IPXL)
Thursday, January 13, 2011 - 11:27am | 193Marketwatch has a list of five biotech stocks to own now, for a wide variety of reasons. The four names the author mentions are Cerus (NASDAQ: CERS), Curis (NASDAQ: CRIS), Compugen (NASDAQ: CGEN), Spectrum Pharmaceuticals (NASDAQ: SPPI), and Impax Laboratories (NASDAQ: IPXL). Regarding Cerus, the...
-
Piper Jaffray Reiterates Overweight Rating on G-III Apparel (GIII)
Thursday, January 13, 2011 - 10:36am | 135Piper Jaffray is out with a research report this morning, where it reiterates its Overweight rating on G-III Apparel. (NASDAQ: GIII); it has a $42.00 price target on the stock. The PJ analysts cited a recent, upbeat investor presentation from Wayne Miller (COO) and Neal Nackman (CFO). While the...
-
Lucentis Gains EU Approval for DME - Analyst Blog
Thursday, January 13, 2011 - 9:46am | 554Novartis AG (NVS) recently received European approval for Lucentis to treat patients with certain forms of diabetic macular edema (DME). It is an eye condition related to long-standing diabetes that may lead to blindness, particularly in working-age population in most developed countries....
-
Lucentis Gains EU Approval for DME - Analyst Blog
Thursday, January 13, 2011 - 9:00am | 554Novartis AG (NVS) recently received European approval for Lucentis to treat patients with certain forms of diabetic macular edema (DME). It is an eye condition related to long-standing diabetes that may lead to blindness, particularly in working-age population in most developed countries....
-
The Cooper Companies Announces $1 Billion Senior Unsecured Credit Facility
Wednesday, January 12, 2011 - 5:03pm | 60The Cooper Companies, Inc. (NYSE: COO) today announced that it entered into a $1 billion 5-year Senior Unsecured Credit Facility, consisting of a $750 million Senior Unsecured Revolving Line of Credit and a $250 million Senior Unsecured Term Loan. The Company also called for the redemption of all $...
-
Short Interest Slides on Healthcare Names (DNEX, BEC, PLL)
Wednesday, January 12, 2011 - 10:38am | 224Jefferies & Company is out with a research report this morning, where it notes that median short interest for Diagnostic and Research Supplies stocks fell 1% and 7%, respectively, in the second half of December. This compares to a 5% absolute decline for both the NYSE and NASDAQ. Short interest...